The global Fluorescent Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fluorescent Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fluorescent Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Fluorescent Imaging in Molecular Biology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Fluorescent Imaging include Abcam, Affymetrix, BD, Biotium, Merck, GE, Jackson Immunoresearch Laboratories, KPL and LI-COR, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fluorescent Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorescent Imaging.
Report Scope
The Fluorescent Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluorescent Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluorescent Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abcam
Affymetrix
BD
Biotium
Merck
GE
Jackson Immunoresearch Laboratories
KPL
LI-COR
Thermo Fisher Scientific
PerkinElmer
R&D Systems
Santa Cruz Biotechnology
Vector Laboratories
Segment by Type
Fluorescence Microscopy/Immunofluorescence
High Content Screening
Fluorescent Immunohistochemistry
Fluorescent In Situ Hybridization (FISH)
Fluorescent Small Animal In Vivo Imaging
Others
Segment by Application
Molecular Biology
Cell Biology
Biochemistry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluorescent Imaging companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Fluorescent Imaging 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fluorescence Microscopy/Immunofluorescence
1.2.3 High Content Screening
1.2.4 Fluorescent Immunohistochemistry
1.2.5 Fluorescent In Situ Hybridization (FISH)
1.2.6 Fluorescent Small Animal In Vivo Imaging
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Fluorescent Imaging 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Molecular Biology
1.3.3 Cell Biology
1.3.4 Biochemistry
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fluorescent Imaging 麻豆原创 Perspective (2019-2030)
2.2 Fluorescent Imaging Growth Trends by Region
2.2.1 Global Fluorescent Imaging 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fluorescent Imaging Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Fluorescent Imaging Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Fluorescent Imaging 麻豆原创 Dynamics
2.3.1 Fluorescent Imaging Industry Trends
2.3.2 Fluorescent Imaging 麻豆原创 Drivers
2.3.3 Fluorescent Imaging 麻豆原创 Challenges
2.3.4 Fluorescent Imaging 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluorescent Imaging Players by Revenue
3.1.1 Global Top Fluorescent Imaging Players by Revenue (2019-2024)
3.1.2 Global Fluorescent Imaging Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Fluorescent Imaging 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fluorescent Imaging Revenue
3.4 Global Fluorescent Imaging 麻豆原创 Concentration Ratio
3.4.1 Global Fluorescent Imaging 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluorescent Imaging Revenue in 2023
3.5 Fluorescent Imaging Key Players Head office and Area Served
3.6 Key Players Fluorescent Imaging Product Solution and Service
3.7 Date of Enter into Fluorescent Imaging 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluorescent Imaging Breakdown Data by Type
4.1 Global Fluorescent Imaging Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Fluorescent Imaging Forecasted 麻豆原创 Size by Type (2025-2030)
5 Fluorescent Imaging Breakdown Data by Application
5.1 Global Fluorescent Imaging Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Fluorescent Imaging Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Fluorescent Imaging 麻豆原创 Size (2019-2030)
6.2 North America Fluorescent Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fluorescent Imaging 麻豆原创 Size by Country (2019-2024)
6.4 North America Fluorescent Imaging 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fluorescent Imaging 麻豆原创 Size (2019-2030)
7.2 Europe Fluorescent Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fluorescent Imaging 麻豆原创 Size by Country (2019-2024)
7.4 Europe Fluorescent Imaging 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fluorescent Imaging 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Fluorescent Imaging 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fluorescent Imaging 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Fluorescent Imaging 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fluorescent Imaging 麻豆原创 Size (2019-2030)
9.2 Latin America Fluorescent Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fluorescent Imaging 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Fluorescent Imaging 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluorescent Imaging 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Fluorescent Imaging 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fluorescent Imaging 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Fluorescent Imaging 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Fluorescent Imaging Introduction
11.1.4 Abcam Revenue in Fluorescent Imaging Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Fluorescent Imaging Introduction
11.2.4 Affymetrix Revenue in Fluorescent Imaging Business (2019-2024)
11.2.5 Affymetrix Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Fluorescent Imaging Introduction
11.3.4 BD Revenue in Fluorescent Imaging Business (2019-2024)
11.3.5 BD Recent Development
11.4 Biotium
11.4.1 Biotium Company Detail
11.4.2 Biotium Business Overview
11.4.3 Biotium Fluorescent Imaging Introduction
11.4.4 Biotium Revenue in Fluorescent Imaging Business (2019-2024)
11.4.5 Biotium Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Fluorescent Imaging Introduction
11.5.4 Merck Revenue in Fluorescent Imaging Business (2019-2024)
11.5.5 Merck Recent Development
11.6 GE
11.6.1 GE Company Detail
11.6.2 GE Business Overview
11.6.3 GE Fluorescent Imaging Introduction
11.6.4 GE Revenue in Fluorescent Imaging Business (2019-2024)
11.6.5 GE Recent Development
11.7 Jackson Immunoresearch Laboratories
11.7.1 Jackson Immunoresearch Laboratories Company Detail
11.7.2 Jackson Immunoresearch Laboratories Business Overview
11.7.3 Jackson Immunoresearch Laboratories Fluorescent Imaging Introduction
11.7.4 Jackson Immunoresearch Laboratories Revenue in Fluorescent Imaging Business (2019-2024)
11.7.5 Jackson Immunoresearch Laboratories Recent Development
11.8 KPL
11.8.1 KPL Company Detail
11.8.2 KPL Business Overview
11.8.3 KPL Fluorescent Imaging Introduction
11.8.4 KPL Revenue in Fluorescent Imaging Business (2019-2024)
11.8.5 KPL Recent Development
11.9 LI-COR
11.9.1 LI-COR Company Detail
11.9.2 LI-COR Business Overview
11.9.3 LI-COR Fluorescent Imaging Introduction
11.9.4 LI-COR Revenue in Fluorescent Imaging Business (2019-2024)
11.9.5 LI-COR Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Fluorescent Imaging Introduction
11.10.4 Thermo Fisher Scientific Revenue in Fluorescent Imaging Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 PerkinElmer
11.11.1 PerkinElmer Company Detail
11.11.2 PerkinElmer Business Overview
11.11.3 PerkinElmer Fluorescent Imaging Introduction
11.11.4 PerkinElmer Revenue in Fluorescent Imaging Business (2019-2024)
11.11.5 PerkinElmer Recent Development
11.12 R&D Systems
11.12.1 R&D Systems Company Detail
11.12.2 R&D Systems Business Overview
11.12.3 R&D Systems Fluorescent Imaging Introduction
11.12.4 R&D Systems Revenue in Fluorescent Imaging Business (2019-2024)
11.12.5 R&D Systems Recent Development
11.13 Santa Cruz Biotechnology
11.13.1 Santa Cruz Biotechnology Company Detail
11.13.2 Santa Cruz Biotechnology Business Overview
11.13.3 Santa Cruz Biotechnology Fluorescent Imaging Introduction
11.13.4 Santa Cruz Biotechnology Revenue in Fluorescent Imaging Business (2019-2024)
11.13.5 Santa Cruz Biotechnology Recent Development
11.14 Vector Laboratories
11.14.1 Vector Laboratories Company Detail
11.14.2 Vector Laboratories Business Overview
11.14.3 Vector Laboratories Fluorescent Imaging Introduction
11.14.4 Vector Laboratories Revenue in Fluorescent Imaging Business (2019-2024)
11.14.5 Vector Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abcam
Affymetrix
BD
Biotium
Merck
GE
Jackson Immunoresearch Laboratories
KPL
LI-COR
Thermo Fisher Scientific
PerkinElmer
R&D Systems
Santa Cruz Biotechnology
Vector Laboratories
听
听
*If Applicable.
